Crandi

Sohonos Ipsen Cares Ipsencares Ca

Leo Migdal
-
sohonos ipsen cares ipsencares ca

After being prescribed SOHONOS®, talk to your health care team about enrolling into IPSEN CARES®. If you are eligible, you will receive a call from IPSEN CARES® confirming your enrolment into the program and offering additional information on services provided. You will have ongoing access to the services outlined above. To request Medical Information or report a Product Quality Complaint for Ipsen Canada’s products, please contact Ipsen Canada at: If you think you or someone you know has experienced an adverse reaction to an Ipsen product, please contact Ipsen Canada at: IPSEN CARES® (Coverage, Access, Reimbursement & Education Support) serves as a central point of contact among patients/caregivers, healthcare providers, insurance companies, and specialty pharmacies.

Actor portrayals unless otherwise noted. We are collecting personal information to fulfill your request. Please see our Privacy Policy and our State Supplemental Privacy Policy for more information. Verifies patients’ coverage, restrictions (if applicable), and copayment/coinsurance amounts Provides information on documentation required by payers on PA specifics and recommendation for next steps based on payer policy The IPSEN CARES® Patient Support Program helps patients get access to their prescribed SohonosTM (palovarotene) with the information and support they need.

SOHONOS is a prescription medicine used to reduce the amount of new heterotopic ossification in adults and children 8 years of age and older for females and 10 years and older for males with... SOHONOS is not recommended for females younger than 8 years of age or males younger than 10 years of age. Do not take SOHONOS if you are pregnant, or allergic to medicines known as retinoids or any of the ingredients in SOHONOS. We are collecting personal information to fulfill your request. Please see our Privacy Policy and our State Supplemental Privacy Policy for more information. Erin, patient living with fibrodysplasia ossificans progressiva (FOP), and her mother, Lori, United States

SOHONOS is FDA approved to reduce the amount of new bone formation of heterotopic ossification or HO (growth outside the skeleton) in adults and children (aged 8 years and above for females and 10... SOHONOS is not recommended for females younger than 8 years of age or males younger than 10 years of age. Ask your doctor if SOHONOS is right for you. This illustration was co-created with people living with FOP. What is the most important information I should know about SOHONOS? SOHONOS can cause birth defects (deformed babies) if taken during pregnancy.

Females who are pregnant or who plan to become pregnant must not take SOHONOS. This website is intended to provide educational materials and information about SOHONOS® to Canadian healthcare professionals and patients who have been prescribed SOHONOS®. Please log in to access our SOHONOS® library. This site uses IQVIA OneKey Web Authentication (OWA) to validate your login. If you already have an OWA account, please log in using this account; otherwise, please register for a new account. The OneKey Web Authentication is managed by a third-party service provider for Ipsen.

Read their Terms of Use. The DIN, or Drug Identification Number, is an 8-digit number found on your prescription package or information brochure. If you do not have your DIN, talk to your doctor or contact the IPSEN CARES® program. IPSEN CARES® (Coverage, Access, Reimbursement & Education Support) is a comprehensive support program that serves as a central point of contact among patients, caregivers, doctors’ offices, insurance companies, and specialty pharmacies. Our priority is to offer services designed to support you throughout your unique treatment journey. For more information about the program, call 1-855-215-2288, Monday to Friday

To request Medical Information or report a Product Quality Complaint for Ipsen Canada’s products, please contact Ipsen Canada at: If you think you or someone you know has experienced an adverse reaction to an Ipsen product, please contact Ipsen Canada at:

People Also Search

After Being Prescribed SOHONOS®, Talk To Your Health Care Team

After being prescribed SOHONOS®, talk to your health care team about enrolling into IPSEN CARES®. If you are eligible, you will receive a call from IPSEN CARES® confirming your enrolment into the program and offering additional information on services provided. You will have ongoing access to the services outlined above. To request Medical Information or report a Product Quality Complaint for Ipse...

Actor Portrayals Unless Otherwise Noted. We Are Collecting Personal Information

Actor portrayals unless otherwise noted. We are collecting personal information to fulfill your request. Please see our Privacy Policy and our State Supplemental Privacy Policy for more information. Verifies patients’ coverage, restrictions (if applicable), and copayment/coinsurance amounts Provides information on documentation required by payers on PA specifics and recommendation for next steps b...

SOHONOS Is A Prescription Medicine Used To Reduce The Amount

SOHONOS is a prescription medicine used to reduce the amount of new heterotopic ossification in adults and children 8 years of age and older for females and 10 years and older for males with... SOHONOS is not recommended for females younger than 8 years of age or males younger than 10 years of age. Do not take SOHONOS if you are pregnant, or allergic to medicines known as retinoids or any of the i...

SOHONOS Is FDA Approved To Reduce The Amount Of New

SOHONOS is FDA approved to reduce the amount of new bone formation of heterotopic ossification or HO (growth outside the skeleton) in adults and children (aged 8 years and above for females and 10... SOHONOS is not recommended for females younger than 8 years of age or males younger than 10 years of age. Ask your doctor if SOHONOS is right for you. This illustration was co-created with people livin...

Females Who Are Pregnant Or Who Plan To Become Pregnant

Females who are pregnant or who plan to become pregnant must not take SOHONOS. This website is intended to provide educational materials and information about SOHONOS® to Canadian healthcare professionals and patients who have been prescribed SOHONOS®. Please log in to access our SOHONOS® library. This site uses IQVIA OneKey Web Authentication (OWA) to validate your login. If you already have an O...